JP2007525494A5 - - Google Patents

Download PDF

Info

Publication number
JP2007525494A5
JP2007525494A5 JP2006552017A JP2006552017A JP2007525494A5 JP 2007525494 A5 JP2007525494 A5 JP 2007525494A5 JP 2006552017 A JP2006552017 A JP 2006552017A JP 2006552017 A JP2006552017 A JP 2006552017A JP 2007525494 A5 JP2007525494 A5 JP 2007525494A5
Authority
JP
Japan
Prior art keywords
alkyl
group
nr9r
aryl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2006552017A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007525494A (ja
JP2007525494A6 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2005/000149 external-priority patent/WO2005074375A2/en
Publication of JP2007525494A publication Critical patent/JP2007525494A/ja
Publication of JP2007525494A6 publication Critical patent/JP2007525494A6/ja
Publication of JP2007525494A5 publication Critical patent/JP2007525494A5/ja
Abandoned legal-status Critical Current

Links

JP2006552017A 2004-02-06 2005-02-06 ヘパラナーゼ阻害剤及びその使用 Abandoned JP2007525494A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54190404P 2004-02-06 2004-02-06
US60/541,904 2004-02-06
PCT/IL2005/000149 WO2005074375A2 (en) 2004-02-06 2005-02-06 Heparanase inhibitors and uses thereof

Publications (3)

Publication Number Publication Date
JP2007525494A JP2007525494A (ja) 2007-09-06
JP2007525494A6 JP2007525494A6 (ja) 2007-12-06
JP2007525494A5 true JP2007525494A5 (https=) 2008-03-21

Family

ID=37074845

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006552017A Abandoned JP2007525494A (ja) 2004-02-06 2005-02-06 ヘパラナーゼ阻害剤及びその使用

Country Status (6)

Country Link
US (1) US20070185176A1 (https=)
EP (1) EP1720828A2 (https=)
JP (1) JP2007525494A (https=)
AU (1) AU2005211255A1 (https=)
CA (1) CA2555313A1 (https=)
WO (1) WO2005074375A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20041129A0 (fi) * 2004-08-30 2004-08-30 Ctt Cancer Targeting Tech Oy Tioksotiatsolidinoniyhdisteitä lääkkeinä käytettäviksi
CA2641421C (en) * 2005-12-30 2014-07-29 Arbor Vita Corporation Small molecule inhibitors of pdz interactions
US8633160B2 (en) * 2005-12-30 2014-01-21 Nono Inc. Small molecule inhibitors of PDZ interactions
CA2641880C (en) 2006-02-10 2014-09-09 Summit Corporation Plc Treatment of duchenne muscular dystrophy
US7875603B2 (en) * 2006-09-21 2011-01-25 Nova Southeastern University Specific inhibitors for vascular endothelial growth factor receptors
CA2685540C (en) * 2007-08-03 2018-10-16 Graham Michael Wynne Drug combinations for the treatment of duchenne muscular dystrophy
GB0715937D0 (en) * 2007-08-15 2007-09-26 Vastox Plc Method of treatment og duchenne muscular dystrophy
CN101544846B (zh) * 2009-05-04 2012-07-04 泰兴市锦鸡染料有限公司 一种活性嫩黄染料及其合成工艺
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
CN103619818A (zh) 2011-06-20 2014-03-05 纳幕尔杜邦公司 用于治疗蠕虫感染的杂环化合物
AU2013229589A1 (en) 2012-03-06 2014-09-11 Compound Handling B.V. Aminomethylene pyrazolones with therapeutic activity
EP2636673A1 (en) * 2012-03-06 2013-09-11 Compound Handling B.V. Aminomethylene pyrazolones with therapeutic activity
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
EP3381906A1 (en) * 2017-03-27 2018-10-03 Leadiant Biosciences SA Compounds for use as heparanase inhibitors
CA3121202A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
WO2020219753A1 (en) * 2019-04-24 2020-10-29 University Of Florida Research Foundation, Incorporated Heparanase compounds and methods of use
CA3226162A1 (en) 2021-07-09 2023-01-12 Plexium, Inc. Aryl compounds and pharmaceutical compositions that modulate ikzf2
CN119174818A (zh) * 2023-06-21 2024-12-24 厦门大学 Otub2抑制剂及其在肿瘤免疫中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002230057A1 (en) * 2001-01-29 2002-08-12 Insight Strategy And Marketing Ltd Diphenyl ether derivatives and their uses as heparanase inhibitors
AU2002228316A1 (en) * 2001-01-29 2002-08-12 Insight Strategy And Marketing Ltd Carbazole derivatives and their uses as heparanase inhibitors

Similar Documents

Publication Publication Date Title
JP2007525494A5 (https=)
US10266496B2 (en) Carboxy substituted (hetero) aromatic ring derivatives and preparation method and uses thereof
ES2797124T3 (es) Cristales
JP2021524838A5 (https=)
CA2674600A1 (en) Formulations for cancer treatment
CN103796654B (zh) 氘富集化4-羟基-5-甲氧基-n,1-二甲基-2-氧代-n-[(4-三氟-甲基)苯基]-1,2-二氢喹啉-3-甲酰胺
JP2021519794A5 (https=)
RU2014150338A (ru) Соединение как ингибитор передачи сигналов wnt, его композиции и применение
JP2019529444A5 (https=)
JP2016505019A5 (https=)
JP2012501346A5 (https=)
JP6270848B2 (ja) ベータ−クロロシクロペンタンの親水性エステルプロドラッグの使用による角膜中央部肥厚の低下
JP2008540532A5 (https=)
CN104010636B (zh) 三环化合物、包含它们的组合物及其用途
CA2565852C (en) 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
JP2020528913A5 (https=)
JP2021510692A5 (https=)
AU2009280042B2 (en) Methods for treating injury associated with exposure to an alkylating species
KR101760970B1 (ko) 신규의 ep4 아고니스트
JP2008508248A5 (https=)
JP2011522825A5 (https=)
TW201310B (https=)
JP5987102B1 (ja) トリアリールメタン組成物，眼膜染色のための染色組成物
JP2006521407A5 (https=)
CN111372579B (zh) 取代的苯基磺酰基苯基三唑硫酮和其用途